Darifenacin HydrobromideExtended-Release (Golden State Medical Supply, Inc.)


Welcome to the PulseAid listing for the Darifenacin Hydrobromide drug offered from Golden State Medical Supply, Inc.. This Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Golden State Medical Supply, Inc.
NON-PROPRIETARY NAME: Darifenacin Hydrobromide
SUBSTANCE NAME: DARIFENACIN HYDROBROMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, EXTENDED RELEASE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-01-18
END MARKETING DATE: 0000-00-00


Darifenacin Hydrobromide Extended-Release HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDarifenacin Hydrobromide Extended-Release from Golden State Medical Supply, Inc.
LABELER NAME: Golden State Medical Supply, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 7.5(mg/1)
START MARKETING DATE: 2017-01-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60429-850_617eeef5-be71-4163-aaea-f536cad44dd0
PRODUCT NDC: 60429-850
APPLICATION NUMBER: ANDA091190

Other DARIFENACIN HYDROBROMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Darifenacin
Aurobindo Pharma LimitedDarifenacin
AvKARE, Inc.Darifenacin Hydrobromide
Cipla USA Inc.Darifenacin
Golden State Medical Supply, Inc.Darifenacin Hydrobromide
Jubilant Cadista Pharmaceuticals Inc.darifenacin
Macleods Pharmaceuticals LimitedDarifenacin
Par PharmaceuticalDarifenacin Hydrobromide
Torrent Pharmaceuticals LimitedDarifenacin
Warner Chilcott (US), LLCEnablex